— -- Question: What is pramlintide and when is it used? Answer: Pramlitide is a synthetic version of the hormone amylin, which is produced in the pancreas from the same cells that make insulin.

Two separate single-center studies (studies A and B) were carried out. Both studies included adult patients (18-70 years of age) with type 1 DM using short- and long-acting insulin products as ...

The addition of pramlintide, an analog of the naturally-occurring β-cell peptide amylin, before meals improves blood glucose control in patients with type 1 diabetes receiving insulin through an ...

Pramlintide use with insulin has been associated with an increased risk of severe hypoglycemia, particularly in patients with type 1 diabetes. About Xeris Pharmaceuticals, Inc.

ADO09, a co-formulation of pramlintide and insulin A21G, was associated with better glucose levels, improved time in range and more weight loss among people with type 1 diabetes compared with ...

The hormone, pramlintide, marketed under the name Symlin, is currently used to treat diabetes. One team of researchers thinks they may have found a new purpose for it.

Following a one-week placebo lead-in period, study subjects were randomized in a balanced fashion to receive twice-daily therapy with one of the following eight treatment regimens: 1) placebo ...

Pramlintide, a synthetic analog of amylin, improves postprandial hyperglycemia. We compared subcutaneous (s.c.) pramlintide injection with square wave pramlintide infusion in adolescents with type ...

Co announces positive results from a 24-week proof-of-concept study with pramlintide, an analog of human amylin, and recombinant human leptin (r-metHuLeptin; metreleptin) combination treatment in ...

Several short-term and long-term clinical trials have shown that the addition of pramlintide to preexisting insulin therapy improved postprandial and overall glycemic control (hemoglobin A 1c ...

(HealthDay) -- The addition of pramlintide, an analog of the naturally-occurring β-cell peptide amylin, before meals improves blood glucose control in patients with type 1 diabetes receiving ...